Xpert Xpress CoV-2/Flu/RSV plus
K-Number: K231481 · 2023-08-17
ApplicantCepheid®
Decision Date2023-08-17
Product CodeQOF
Advisory CommitteeMI
DecisionSubstantially Equivalent
Device Summary
Xpert Xpress CoV-2/Flu/RSV plus is a medical device manufactured by Cepheid®. It received FDA 510(k) clearance on 2023-08-17 under approval number K231481. The device is classified under product code QOF. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Xpert Xpress CoV-2/Flu/RSV plus?
Xpert Xpress CoV-2/Flu/RSV plus is a medical device that received FDA 510(k) clearance on 2023-08-17. It is manufactured by Cepheid®. The 510(k) number is K231481.
When was Xpert Xpress CoV-2/Flu/RSV plus approved by the FDA?
Xpert Xpress CoV-2/Flu/RSV plus received FDA 510(k) clearance on 2023-08-17, under approval number K231481.
What company makes Xpert Xpress CoV-2/Flu/RSV plus?
Xpert Xpress CoV-2/Flu/RSV plus is manufactured by Cepheid®.
What is the FDA product code for Xpert Xpress CoV-2/Flu/RSV plus?
The FDA product code for Xpert Xpress CoV-2/Flu/RSV plus is QOF.
Other Devices by Cepheid®
Related Devices (Code: QOF)
DEN200031BioFire Respiratory Panel 2.1 (RP2.1)Biofire Diagnostics, LLC
K230956BD Respiratory Viral Panel for BD MAX System; BD Respiratory Viral Panel-SCV2 for BD MAX SystemBd Integrated Diagnostic Solutions /
K223591cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® SystemRoche Molecular Systems, Inc.
K222736Panther Fusion SARS-CoV-2/Flu A/B/RSV AssayHologic, Inc.
K230719BIOFIRE® SPOTFIRE® Respiratory (R) Panel MiniBiofire Diagnostics, LLC
K220963Simplexa COVID-19 & Flu A/B DirectDiasorin Molecular, LLC
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.